-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HaOdgtVRoqPB9tdFZxr37Revt/4kg/9iF0itA95qHLZgk6fCtpOKCZoCZ2tze8e+ bX6SMijyoTiKNMuvH+qU1A== 0001209191-10-005417.txt : 20100129 0001209191-10-005417.hdr.sgml : 20100129 20100129105645 ACCESSION NUMBER: 0001209191-10-005417 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100127 FILED AS OF DATE: 20100129 DATE AS OF CHANGE: 20100129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boland James C CENTRAL INDEX KEY: 0001203531 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 10556168 MAIL ADDRESS: STREET 1: 101 PROSPECT AVENUE, N.W. CITY: CLEVELAND STATE: OH ZIP: 44115 FORMER NAME: FORMER CONFORMED NAME: BOLAND JAMES C DATE OF NAME CHANGE: 20021105 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-01-27 0 0000742112 INVACARE CORP IVC 0001203531 Boland James C ONE INVACARE WAY ELYRIA OH 44035 1 0 0 0 Common Shares 2010-01-27 4 M 0 1000 19.50 A 12276.582 D Stock Option (Right to Buy) 19.50 2010-01-27 4 M 0 1000 0.00 D 2001-03-31 2010-02-04 Common Shares 1000 0 D Stock Option (Right to Buy) Common Shares 66650 66650 D No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5. The reporting person holds previously reported options to buy 66,650 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between November 14, 2000 and December 11, 2009, at an exercise price between $10.695 and $47.01 per share, will expire between November 14, 2010 and August 20, 2018 and became or will become exercisable between December 31, 2001 and January 1, 2013. /s/ James C. Boland, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated February 12, 2009 on file with the Commission. 2010-01-29 -----END PRIVACY-ENHANCED MESSAGE-----